ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 84 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $460,000 | +77.6% | 62,100 | 0.0% | 0.09% | +61.8% |
| Q2 2020 | $259,000 | +181.5% | 62,100 | +67.4% | 0.06% | +52.8% |
| Q1 2020 | $92,000 | -57.4% | 37,100 | 0.0% | 0.04% | +5.9% |
| Q4 2019 | $216,000 | -12.9% | 37,100 | -21.2% | 0.03% | -39.3% |
| Q3 2019 | $248,000 | -12.1% | 47,100 | 0.0% | 0.06% | +27.3% |
| Q2 2019 | $282,000 | -40.0% | 47,100 | -9.6% | 0.04% | -51.1% |
| Q1 2019 | $470,000 | +8.8% | 52,100 | 0.0% | 0.09% | -17.4% |
| Q4 2018 | $432,000 | -43.1% | 52,100 | -5.3% | 0.11% | +6.9% |
| Q3 2018 | $759,000 | +112.0% | 55,000 | +22.2% | 0.10% | +88.9% |
| Q2 2018 | $358,000 | +6.5% | 45,000 | 0.0% | 0.05% | +8.0% |
| Q1 2018 | $336,000 | +9.8% | 45,000 | 0.0% | 0.05% | +35.1% |
| Q4 2017 | $306,000 | +7.4% | 45,000 | +13.8% | 0.04% | -2.6% |
| Q3 2017 | $285,000 | +109.6% | 39,552 | +35.9% | 0.04% | +245.5% |
| Q2 2017 | $136,000 | – | 29,104 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 473,446 | $5,625,000 | 4.61% |
| Knoll Capital Management, LLC | 569,405 | $6,765,000 | 4.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 321,879 | $3,824,000 | 2.09% |
| First Light Asset Management, LLC | 2,624,001 | $31,173,000 | 2.07% |
| Mesirow Financial Investment Management, Inc. | 63,634 | $756,000 | 2.06% |
| Ghost Tree Capital, LLC | 650,000 | $7,722,000 | 1.82% |
| Altium Capital Management LP | 548,225 | $6,513,000 | 1.81% |
| Perceptive Advisors | 8,703,879 | $103,402,000 | 1.31% |
| Affinity Asset Advisors, LLC | 300,000 | $3,564,000 | 1.21% |
| Avidity Partners Management LP | 2,552,000 | $30,318,000 | 0.84% |